Russia Nuclear Medicine Market Size & Outlook, 2023-2030
Russia nuclear medicine market, 2018-2030 (US$M)
Related Markets
Russia nuclear medicine market highlights
- The Russia nuclear medicine market generated a revenue of USD 119.9 million in 2023 and is expected to reach USD 277.3 million by 2030.
- The Russia market is expected to grow at a CAGR of 12.7% from 2024 to 2030.
- In terms of segment, diagnostics was the largest revenue generating product in 2023.
- Therapeutics is the most lucrative product segment registering the fastest growth during the forecast period.
Nuclear medicine market data book summary
| Market revenue in 2023 | USD 119.9 million |
| Market revenue in 2030 | USD 277.3 million |
| Growth rate | 12.7% (CAGR from 2023 to 2030) |
| Largest segment | Diagnostics |
| Fastest growing segment | Therapeutics |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diagnostics, Therapeutics |
| Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Jubilant Pharmova, Nordion, Bracco, Iren SpA, Abliva AB, Lantheus Holdings Inc, Eckert & Ziegler Bebig SA, Mallinckrodt PLC Ordinary Shares - New, Cardinal Health Inc |
Other key industry trends
- In terms of revenue, Russia accounted for 1.2% of the global nuclear medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany nuclear medicine market is projected to lead the regional market in terms of revenue in 2030.
- Netherlands is the fastest growing regional market in Europe and is projected to reach USD 279.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Nuclear Medicine Market Scope
Nuclear Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Russia nuclear medicine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nuclear medicine market will help companies and investors design strategic landscapes.
Diagnostics was the largest segment with a revenue share of 61.3% in 2023. Horizon Databook has segmented the Russia nuclear medicine market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.
For the past few decades, Russia has been focusing on strengthening its position in the international nuclear medicine market for diagnostic and therapeutic purposes. In 2017, The State Atomic Energy Corporation ROSATOM formed a company called Rosatom Healthcare to promote nuclear technologies and export of nuclear medicine worldwide.
Moreover, the Scientific Research Institute for Nuclear Reactors (NIIAR) develops and produces several medical isotopes, such as iodine-131, lutetium -177, tungstern-188, strontium-89, and iodine - 125. Rosatom also has a molybdenum-99 production set up in NIIAR. Nearly 60% of isotope products are manufactured at the PO, Mayak. It is the only site in Russia where plutonium-238 is produced.
This plant produces several radioisotope compounds, and nearly 90% of these compounds are exported. Key producers of radioisotopes in Russia are Siberian Chemical Enterprises and Electrochemical Plant, which is also a major producer of stable radioisotopes.
Reasons to subscribe to Russia nuclear medicine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Russia nuclear medicine market databook
-
Our clientele includes a mix of nuclear medicine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Russia nuclear medicine market , including forecasts for subscribers. This country databook contains high-level insights into Russia nuclear medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Russia nuclear medicine market size, by product, 2018-2030 (US$M)
Russia Nuclear Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
